MPM BioImpact LLC Diversified Active

CIK: 0001687078 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 11, 2022

Total Value ($000): $359,998 (100.0% shares, 0.0% debt)

Holdings (37)

CGEM Cullinan Oncology, Inc. 27.2%
Value ($000) $98,051 Shares 7,648,268 Est. Cost $40.60 Unrealized -72.1%
iTeos Therapeutics, Inc. 10.0%
Value ($000) $35,966 Shares 1,745,943 Est. Cost $24.67 Unrealized
Repare Therapeutics, Inc. 6.4%
Value ($000) $22,941 Shares 1,639,849 Est. Cost $31.02 Unrealized
Merus N.V. 5.8%
Value ($000) $20,817 Shares 919,482 Est. Cost $17.60 Unrealized
NTLA Intellia Therapeutics, Inc. 4.3%
Value ($000) $15,497 Shares 299,409 Est. Cost $104.35 Unrealized -51.3%
IOVA Iovance Biotherapeutics Inc Com 3.7%
Value ($000) $13,248 Shares 1,200,000 Est. Cost $13.10 Unrealized 0.0%
GERN Geron Corporation 3.6%
Value ($000) $13,074 Shares 8,434,991 Est. Cost $1.34 Unrealized +5.3%
Inhibrx, Inc. 3.2%
Value ($000) $11,615 Shares 1,023,325 Est. Cost $11.35 Unrealized
TCR2 Therapeutics, Inc. 2.7%
Value ($000) $9,776 Shares 3,370,982 Est. Cost $14.28 Unrealized
HOWL Werewolf Therapeutics, Inc. 2.7%
Value ($000) $9,767 Shares 2,388,011 Est. Cost $13.70 Unrealized -66.7%
CYTK Cytokinetics Inc. 2.1%
Value ($000) $7,632 Shares 194,246 Est. Cost $29.44 Unrealized +36.7%
CRNX Crinetics Pharmaceuticals Inc. 1.9%
Value ($000) $6,839 Shares 366,676 Est. Cost $21.72 Unrealized -8.1%
BCRX Biocryst Pharmaceuticals Inc. 1.9%
Value ($000) $6,762 Shares 639,089 Est. Cost $15.77 Unrealized -34.6%
TVTX Travere Therapeutics Inc. 1.9%
Value ($000) $6,735 Shares 277,950 Est. Cost $18.37 Unrealized +36.9%
YmAbs Therapeutics, Inc. 1.9%
Value ($000) $6,713 Shares 443,702 Est. Cost $30.56 Unrealized
HRMY Harmony Biosciences Hldgs Inc. 1.9%
Value ($000) $6,707 Shares 137,517 Est. Cost $32.20 Unrealized +39.8%
Harpoon Therapeutics, Inc. 1.7%
Value ($000) $6,106 Shares 3,196,707 Est. Cost $14.79 Unrealized
MIRM Mirum Pharmaceuticals Inc. 1.6%
Value ($000) $5,615 Shares 288,531 Est. Cost $16.26 Unrealized +45.0%
ARQT Arcutis Biotherapeutics inc 1.5%
Value ($000) $5,509 Shares 258,500 Est. Cost $16.92 Unrealized +21.3%
Reata Pharmaceuticals inc-a 1.5%
Value ($000) $5,470 Shares 180,000 Est. Cost $32.76 Unrealized
FOLD Amicus Therapeutics Inc. 1.5%
Value ($000) $5,323 Shares 495,603 Est. Cost $10.23 Unrealized -19.5%
Epizyme, Inc. 1.4%
Value ($000) $5,035 Shares 3,425,202 Est. Cost $15.19 Unrealized
G1 Therapeutics, Inc. 1.2%
Value ($000) $4,233 Shares 856,798 Est. Cost $25.71 Unrealized
Verastem, Inc. 1.0%
Value ($000) $3,764 Shares 3,244,650 Est. Cost $2.94 Unrealized
MDGL Madrigal Pharmaceuticals inc 0.9%
Value ($000) $3,221 Shares 45,000 Est. Cost $73.50 Unrealized 0.0%
Inozyme Pharma Inc. 0.9%
Value ($000) $3,172 Shares 664,980 Est. Cost $7.80 Unrealized
Oncorus, Inc. 0.8%
Value ($000) $2,995 Shares 2,377,031 Est. Cost $32.33 Unrealized
RVMD Revolution Medicines, Inc. 0.8%
Value ($000) $2,846 Shares 146,041 Est. Cost $29.11 Unrealized -33.1%
ADCT ADC Therapeutics, Inc. 0.7%
Value ($000) $2,658 Shares 334,384 Est. Cost $33.59 Unrealized -71.8%
Karuna Therapeutics inc 0.7%
Value ($000) $2,530 Shares 20,000 Est. Cost $126.80 Unrealized
Provention Bio Inc 0.7%
Value ($000) $2,370 Shares 592,435 Est. Cost $4.00 Unrealized
ESSA Pharma, Inc. 0.6%
Value ($000) $2,082 Shares 660,892 Est. Cost $8.00 Unrealized
PHAT Phathom Pharmaceuticals inc 0.5%
Value ($000) $1,632 Shares 193,326 Est. Cost $16.15 Unrealized -36.4%
NEO Neogenomics Inc. 0.3%
Value ($000) $1,105 Shares 135,573 Est. Cost $46.29 Unrealized -79.4%
Avadel Pharmaceuticals Plc 0.3%
Value ($000) $1,006 Shares 412,363 Est. Cost $9.53 Unrealized
AVROBIO, Inc. 0.2%
Value ($000) $596 Shares 647,918 Est. Cost $5.58 Unrealized
BDTX Black Diamond Therapeutics, Inc. 0.2%
Value ($000) $590 Shares 239,888 Est. Cost $9.87 Unrealized -76.5%